RESUMEN
Oxidative stress with higher levels of leptin and inflammatory response are key processes related to pathogenesis of both T. cruzi infection and aging. Nuclear factor erythroid 2-related factor 2 (Nrf2) controls the expression of several genes implicated in the oxidative stress response in many pathological conditions. Melatonin is a pleiotropic hormone with, antioxidant, anti-inflammatory and anti-aging actions. Then, we hypothesized that Nrf2 response is impaired during the acute T. cruzi (9 days) infection and that melatonin rescues Nrf2 responses. Young (5 weeks-old) and middle-aged (18 months-old) male Wistar rats were infected with T. cruzi. Nrf2 translocation and markers of inflammation and oxidative stress were analyzed in blood and spleen. Increased apoptosis levels and oxidative stress indicators were observed in the rat spleen during T. cruzi infection. These responses were accompanied by decreased Nrf2 expression and increased expression of nuclear factor kappa B (NFκB). Melatonin (5 mg/kg/day; p.o. gavage) attenuated the superoxide anion (O2-) and hydrogen peroxide (H2O2) production induced by T. cruzi infection. Increased expressions of catalase and superoxide dismutase (SOD) were detected in the spleen of melatonin-treated rats infected with T. cruzi. Melatonin treatment inhibited the spleen NF-κB activation and downregulates the levels of circulating interleukin (IL)-4, IL-10 and tumor necrosis factor (TNF)-α in T. cruzi middle-aged infected rats. Increased levels of the chemokine CXCL1 in middle-aged control rats was observed, confirming that aging alters the production of this chemokine. In T. cruzi infected young animals, CXCL1 was up-regulated when compared to non-infected young ones. For young or middle-aged animals, melatonin treatment had no significant effect on CXCL1 levels. Our findings demonstrate an important role for Nrf2/NF-kB regulation as a possible mechanism by which melatonin attenuates oxidative stress, and provide new insights for further studies of this indoleamine as a therapeutic co-adjuvant agent against T. cruzi infection.
Asunto(s)
Enfermedad de Chagas , Melatonina , Animales , Antioxidantes/metabolismo , Antioxidantes/farmacología , Peróxido de Hidrógeno/farmacología , Masculino , Melatonina/farmacología , Factor 2 Relacionado con NF-E2/metabolismo , FN-kappa B/metabolismo , Estrés Oxidativo , Ratas , Ratas WistarRESUMEN
Chagas disease, triggered by the flagellate protozoan Trypanosoma cruzi (T. cruzi) plays a potentially threat to historically non-endemic areas. Considerable evidence established that the immuno-endocrine balance could deeply influence the experimental T. cruzi progression inside the host's body. A high-resolution multiple reaction monitoring approach (MRMHR) was used to study the influence of melatonin on adrenal and plasma steroidal hormones profile of T. cruzi infected Wistar rats. Young (5â¯weeks) and middle-aged (18â¯months) male Wistar rats received melatonin (5â¯mg/Kg, orally) during the acute Chagas disease. Corticosterone, 11-dehydrocorticosterone (11-DHC), cortisol, cortisone, aldosterone, progesterone and melatonin concentration were evaluated. Interleukin-1 alpha and ß (IL-1α and ß), IL-6 and transforming growth factor beta (TGF-ß) were also analyzed. Our results revealed an increased production of corticosterone, cortisone, cortisol and aldosterone in middle-aged control animals, thus confirming the aging effects on the steroidal hormone profile. Serum melatonin levels were reduced with age and predominantly higher in young and middle-aged infected rats. Melatonin treatment reduced the corticosterone, 11-DHC, cortisol, cortisone, aldosterone and progesterone in response to T. cruzi infection. Decreased IL-1 α and ß concentrations were also found in melatonin treated middle-aged infected animals. Melatonin treated middle-aged control rats displayed reduced concentrations of TGF-ß. Melatonin levels were significantly higher in all middle-aged rats treated animals. Reduced percentages of early and late thymocyte apoptosis was found for young and middle-aged melatonin supplemented rats. Finally, our results show a link between the therapeutic and biological effects of melatonin controlling steroidal hormones pathways as well as inflammatory mediators.
Asunto(s)
Citocinas/sangre , Melatonina/sangre , Envejecimiento/sangre , Envejecimiento/metabolismo , Aldosterona/sangre , Animales , Apoptosis/efectos de los fármacos , Corticosterona/sangre , Cortisona/sangre , Interleucina-1alfa/sangre , Interleucina-1beta/sangre , Masculino , Ratas , Ratas Wistar , Espectrometría de Masas en Tándem , Timocitos/efectos de los fármacos , Timocitos/metabolismo , Trypanosoma cruzi/patogenicidadRESUMEN
Chagas disease induces a strong immune response and L-arginine is an essential amino acid which plays an important role in homeostasis of the immune system. The aims of this study were to evaluate parasitemia, corticosterone levels, production of nitric oxide (NO), fetal morphological measurements, and histology of heart and placenta. Twenty pregnant Wistar rats (180-220 g) were grouped in: pregnant control (PC), pregnant control and L-arginine supplied (PCA), pregnant infected (PI), pregnant infected and L-arginine supplied (PIA). Females were infected with 1×10(5) trypomastigotes of the Y strain (3rd day of pregnancy). Animals were supplied with 21 mg of L-arginine/kg/day during 14 days. PIA showed significant decreased levels of corticosterone and parasitemia. For control groups, any alteration in NO production was found with L-arginine supplementation; for PIA, enhanced nitrite concentrations were observed as compared to PI. Weights and lengths of fetuses were higher in L-arginine treated and infected pregnant rats as compared to untreated ones. Placental weight from the PIA group was significantly increased when compared to PI. In L-arginine treated animals, cardiac tissue showed reduced amastigote burdens. PIA and PI displayed similar placental parasitism. Based on these results, L-arginine supplementation may be potentially useful for the protection against Trypanosoma cruzi during pregnancy.
Asunto(s)
Arginina/metabolismo , Enfermedad de Chagas/inmunología , Complicaciones Parasitarias del Embarazo/inmunología , Trypanosoma cruzi/inmunología , Animales , Arginina/administración & dosificación , Enfermedad de Chagas/embriología , Corticosterona/sangre , Suplementos Dietéticos , Femenino , Desarrollo Fetal/efectos de los fármacos , Feto/parasitología , Corazón/parasitología , Miocardio/patología , Óxido Nítrico/metabolismo , Parasitemia/inmunología , Placenta/parasitología , Placenta/patología , Embarazo , Distribución Aleatoria , Ratas , Ratas Wistar , Bazo/citología , Bazo/inmunologíaRESUMEN
BACKGROUND & AIMS: The occurrence of infectious disease processes during pregnancy has significant effects on maternal health and can lead to adverse pregnancy outcomes. The aim of the present study was to examine the potential role of zinc treatment during Trypanosoma cruzi infection in pregnant animals. METHODS: Female Wistar rats weighing 180-200 g were used in all experiments. Production of nitric oxide, peritoneal macrophages counts, and concentrations of IFN-γ and TNF-α were measured, and the potential protective effects of zinc on fetal development were assessed at 14-day post-infection. RESULTS: Nitric oxide concentrations were higher in pregnant zinc-treated animals than in their untreated counterparts, despite similar levels of the macrophages, IFN-γ and TNF-α. Zinc therapy was associated with a significant reduction in parasitemia and cardiac parasite burden. Higher placental and birth weights were observed in animals given prenatal zinc supplementation compared to untreated animals. CONCLUSIONS: These data confirm the critical importance of adequate zinc intake during the peri-conceptional period and indicate that zinc has an effective role in preventing adverse outcomes of pregnancy and reducing the risk of common infections such as Chagas' disease.
Asunto(s)
Enfermedad de Chagas/tratamiento farmacológico , Enfermedad de Chagas/inmunología , Suplementos Dietéticos , Complicaciones Parasitarias del Embarazo/inmunología , Zinc/administración & dosificación , Animales , Femenino , Corazón/efectos de los fármacos , Corazón/parasitología , Interferón gamma/sangre , Macrófagos Peritoneales/inmunología , Óxido Nítrico/sangre , Parasitemia/prevención & control , Embarazo , Complicaciones Parasitarias del Embarazo/tratamiento farmacológico , Ratas , Ratas Wistar , Trypanosoma cruzi/crecimiento & desarrollo , Factor de Necrosis Tumoral alfa/sangreRESUMEN
The ability of the gonadal hormones to influence diverse immunological functions during the course of several infections has been extensively studied in the latest decades. Testosterone has a suppressive effect on immune response of vertebrates and increases susceptibility toward numerous parasitic diseases. Dehydroepiandrosterone is an abundant steroid hormone secreted by the human adrenal cortex and it is considered potent immune-activator. In this paper, it was examined the effects of DHEA and testosterone supplementation in the thymic atrophy in rats infected with Trypanosoma cruzi, by comparing blood parasitism, thymocyte proliferation, TNF-alpha and IL-12 levels. Our data point in the direction that DHEA treatment triggered enhanced thymocyte proliferation as compared to its infected counterparts and reduced production of TNF-alpha during the acute phase of infection. Oppositely, the lowest values for cells proliferation and IL-12 concentrations were reached in testosterone-supplied animals. The combined treatment testosterone and DHEA improves the effectiveness of the host's immune response, reducing blood parasites and the immunosuppressive effects of male androgens besides increasing IL-12 concentrations and decreasing TNF-alpha levels.
Asunto(s)
Antiprotozoarios/uso terapéutico , Enfermedad de Chagas/tratamiento farmacológico , Deshidroepiandrosterona/uso terapéutico , Testosterona/uso terapéutico , Timo/efectos de los fármacos , Animales , Antiprotozoarios/efectos adversos , Deshidroepiandrosterona/efectos adversos , Interleucina-12/sangre , Masculino , Parasitemia , Ratas , Ratas Wistar , Testosterona/efectos adversos , Timo/citología , Trypanosoma cruzi , Factor de Necrosis Tumoral alfa/sangreRESUMEN
Chagas' disease is considered the sixth most important neglected tropical disease worldwide. Considerable knowledge has been accumulated concerning the role of zinc on cellular immunity. The steroid hormone dehydroepiandrosterone (DHEA) is also known to modulate the immune system. The aims of this paper were to investigate a possible synchronization of their effects on cytokines and NO production and the resistance to Trypanosoma cruzi during the acute phase of infection. It was found that zinc, DHEA or zinc and DHEA supplementation enhanced the immune response, as evidenced by a significant reduction in parasitemia levels. Zinc and DHEA supplementation exerted additive effects on the immune response by elevation of macrophage counts, and by increasing concentrations of IFN-gamma and NO.
Asunto(s)
Adyuvantes Inmunológicos/farmacología , Enfermedad de Chagas/inmunología , Deshidroepiandrosterona/farmacología , Depuradores de Radicales Libres/farmacología , Factores Inmunológicos/farmacología , Células TH1/efectos de los fármacos , Trypanosoma cruzi , Zinc/farmacología , Animales , Recuento de Células , Enfermedad de Chagas/metabolismo , Citocinas/biosíntesis , Interferón gamma/análisis , Interferón gamma/biosíntesis , Macrófagos Peritoneales/citología , Macrófagos Peritoneales/inmunología , Masculino , Óxido Nítrico/análisis , Óxido Nítrico/biosíntesis , Ratas , Ratas Wistar , Células TH1/inmunologíaRESUMEN
Zinc is an essential nutritional component required for normal development and maintenance of immune functions. The possible effects of zinc in upregulating the host immune response during the acute and chronic phases of experimental Chagas' disease were evaluated. In young, infected and Zn-supplemented animals, higher concentrations of IFN-gamma and NO were observed. During the chronic phase, decreased concentrations of NO and IFN-gamma were found for older infected animals that received Zn supplementation. For young animals, hearts from Zn-supplemented groups displayed reduced inflammatory infiltrate, heart weight and number of amastigote burdens. For older, infected and Zn-supplemented animals amastigote nests were absent with reduced inflammatory cell infiltrate. This study identifies a potentially novel therapeutic approach that could control the parasite load during acute phase of disease, consequently preventing the deleterious, parasite-elicited responses observed during chronic phase.
Asunto(s)
Enfermedad de Chagas/inmunología , Interferón gamma/biosíntesis , Óxido Nítrico/biosíntesis , Trypanosoma cruzi/inmunología , Sulfato de Zinc/administración & dosificación , Animales , Enfermedad de Chagas/tratamiento farmacológico , Enfermedad de Chagas/patología , Corazón/parasitología , Interferón gamma/sangre , Macrófagos Peritoneales/metabolismo , Masculino , Miocardio/patología , Tamaño de los Órganos , Ratas , Ratas Wistar , Trypanosoma cruzi/efectos de los fármacosRESUMEN
The ability of gonadal hormones to influence and induce diverse immunological functions during the course of a number of parasitic infections has been extensively studied in the latest decades. Dehydroepiandrosterone and its sulfate are the most abundant steroid hormones secreted by the human adrenal cortex and are considered potent immune-activators. The effects of orchiectomy on the course of Trypanosoma cruzi infection in rats, treated and untreated with DHEA were examined, by comparing blood and cardiac parasitism, macrophage numbers, nitric oxide and IFN-gamma levels. Orchiectomy enhanced resistance against infection with elevated numbers of macrophages, enhanced concentrations of NO and IFN-gamma and reduced amastigote burdens in heart when compared to control animals. DHEA replacement exerted a synergistic effect, up-modulating the immune response. Male sex steroids appear to play fundamental role in determining the outcome of disease, through the regulation and modulation of the activity of the immune response.
Asunto(s)
Adyuvantes Inmunológicos/uso terapéutico , Enfermedad de Chagas/tratamiento farmacológico , Deshidroepiandrosterona/uso terapéutico , Trypanosoma cruzi/efectos de los fármacos , Adyuvantes Inmunológicos/farmacología , Animales , Recuento de Células , Enfermedad de Chagas/inmunología , Enfermedad de Chagas/cirugía , Deshidroepiandrosterona/farmacología , Corazón/parasitología , Interferón gamma/sangre , Macrófagos Peritoneales/citología , Macrófagos Peritoneales/efectos de los fármacos , Macrófagos Peritoneales/inmunología , Masculino , Miocardio/patología , Óxido Nítrico/biosíntesis , Orquiectomía , Parasitemia/inmunología , Parasitemia/parasitología , Ratas , Ratas Wistar , Trypanosoma cruzi/inmunologíaRESUMEN
It is well recognized that zinc is an essential trace element for all organisms, influencing growth and affecting the development and integrity of the immune system. It is also well known that the protective response against Trypanosoma cruzi depends on both innate and acquired immunity and for the control of the parasite load and host survival, the participation of special cells such natural killer (NK), T and B lymphocytes and macrophages are required. So the aims of this study were to evaluate the effects of zinc supplementation on the host's immune response infected with T. cruzi. Our data point in the direction that zinc supplementation triggered enhanced thymocyte and splenocyte proliferation as compared to unsupplied group of animals. It is also important to emphasize that interleukin-12 (IL-12) participates in the resistance to several intracellular pathogens including T. cruzi. Our findings demonstrate an enhanced production of IL-12 during the acute phase of infection in zinc-supplied groups. So we conclude that zinc supplementation leads to an effective host's immune response by up-modulating the host's immune response, thus contributing in the reduction of blood parasites and the harmful pathogenic effects of the experimental Chagas' disease.
Asunto(s)
Tripanosomiasis/prevención & control , Zinc/farmacología , Animales , Concanavalina A/farmacología , Interleucina-12/metabolismo , Masculino , Parasitemia/tratamiento farmacológico , Ratas , Ratas Wistar , Bazo/citología , Bazo/efectos de los fármacos , Timo/citología , Timo/efectos de los fármacos , Factores de Tiempo , Trypanosoma cruziRESUMEN
Dehydroepiandrosterone (DHEA) enhances immune responses against a wide range of viral, bacterial, and parasitic pathogens. In a previous study, we reported that administration of DHEA significantly decreased the numbers of blood parasites in Trypanosoma cruzi experimental infection. The present study was undertaken to determine the effectiveness of DHEA in reducing the severity of acute phase T. cruzi infection of male and female Wistar rats. Animals were treated subcutaneously with 40 mg/kg body weight/day of DHEA. The concentration of nitric oxide (NO) was determined in spleen peritoneal cavity. Interleukin-2 (IL-2) and interferon-gamma (IFN-gamma) were determined in the sera of uninfected and infected animals. DHEA treatment augments NO production for both sexes after in vitro LPS treatment for uninfected animals. Infection triggered enhanced NO levels although not significant. IL-2 and IFN-gamma were detectable in higher concentrations in treated and infected rats of both genders when compared to untreated controls. These data suggest that DHEA may have a potent immunoregulatory function that can affect the course of T. cruzi infection.
Asunto(s)
Adyuvantes Inmunológicos/uso terapéutico , Enfermedad de Chagas/prevención & control , Deshidroepiandrosterona/uso terapéutico , Trypanosoma cruzi/efectos de los fármacos , Adyuvantes Inmunológicos/sangre , Animales , Enfermedad de Chagas/sangre , Enfermedad de Chagas/inmunología , Enfermedad de Chagas/parasitología , Deshidroepiandrosterona/sangre , Deshidroepiandrosterona/inmunología , Femenino , Interferón gamma/sangre , Interleucina-2/sangre , Masculino , Óxido Nítrico , Distribución Aleatoria , Ratas , Ratas Wistar , Índice de Severidad de la Enfermedad , Trypanosoma cruzi/patogenicidadRESUMEN
It is well recognized that zinc is an essential trace element, influencing growth and affecting the development and integrity of the immune system. The use of oligoelements as zinc can be considered a tool in modulating the effectiveness of the immune response. In this work zinc was daily and orally supplied in male Wistar rats infected with the Y strain of Trypanosoma cruzi. Parasitemia was evaluated and a significant reduction on blood parasites was observed. In order to check some immunological parameters peritoneal macrophages were counted revealing higher percentages for zinc supplied group. Consequently enhanced concentrations of IFN-gamma was found and for the first time NO was evaluated in T. cruzi infected animals under the influence of zinc therapy, revealing enhanced concentrations when compared to unsupplied counterparts. We conclude that zinc is able to up-regulate the host's immune response against parasite replication.